To include your compound in the COVID-19 Resource Center, submit it here.

Grifols to acquire Talecris

Grifols S.A. (Madrid:GRF) plans to acquire fellow plasma protein company Talecris Biotherapeutics Inc. (NASDAQ:TLCR) in a cash and stock

Read the full 196 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE